Cellectis Valuation
| CLLS Stock | USD 2.13 0.01 0.47% |
Based on Macroaxis valuation methodology, the firm appears to be undervalued. Cellectis SA shows a prevailing Real Value of $3.38 per share. The current price of the firm is $2.13. Our model approximates the value of Cellectis SA from analyzing the firm fundamentals such as Return On Equity of -0.82, current valuation of 33.49 M, and Profit Margin of (2.34) % as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Cellectis' valuation include:
Price Book 1.6473 | Enterprise Value 33.5 M | Enterprise Value Ebitda (3.90) | Price Sales 5.9153 | Enterprise Value Revenue 1.1521 |
Undervalued
Today
Please note that Cellectis' price fluctuation is relatively risky at this time. Calculation of the real value of Cellectis SA is based on 3 months time horizon. Increasing Cellectis' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Cellectis stock is determined by what a typical buyer is willing to pay for full or partial control of Cellectis SA. Since Cellectis is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Cellectis Stock. However, Cellectis' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.13 | Real 3.38 | Target 7.5 | Hype 2.13 | Naive 2.21 |
The intrinsic value of Cellectis' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Cellectis' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Cellectis SA helps investors to forecast how Cellectis stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Cellectis more accurately as focusing exclusively on Cellectis' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Cellectis' intrinsic value based on its ongoing forecasts of Cellectis' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Cellectis' closest peers.
Cellectis Cash |
|
Cellectis Valuation Trend
Cellectis' real value is important for investors to make better decisions and a more accurate overall view of Cellectis' financial worth over time. Using both Cellectis' enterprise value as well as its market capitalization is the best way to gauge the value of the company and is usually enough for investors to make market timing conclusions.
Cellectis Total Value Analysis
Cellectis SA is currently expected to have valuation of 33.49 M with market capitalization of 213.2 M, debt of 92.85 M, and cash on hands of 153.13 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Cellectis fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
33.49 M | 213.2 M | 92.85 M | 153.13 M |
Cellectis Investor Information
About 15.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.65. Some equities with similar Price to Book (P/B) outperform the market in the long run. Cellectis SA recorded a loss per share of 1.16. The entity had not issued any dividends in recent years. Based on the key indicators related to Cellectis' liquidity, profitability, solvency, and operating efficiency, Cellectis SA is not in a good financial situation at this time. It has a very high odds of going through financial crisis in December.Cellectis Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Cellectis has an asset utilization ratio of 0.23 percent. This implies that the Company is making $0.002259 for each dollar of assets. An increasing asset utilization means that Cellectis SA is more efficient with each dollar of assets it utilizes for everyday operations.Cellectis Ownership Allocation
Cellectis holds a total of 100.09 Million outstanding shares. Cellectis SA shows 3.86 percent of its outstanding shares held by insiders and 14.76 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Cellectis Profitability Analysis
The company reported the previous year's revenue of 755 K. Net Loss for the year was (116.83 M) with profit before overhead, payroll, taxes, and interest of 23.95 M.About Cellectis Valuation
The stock valuation mechanism determines Cellectis' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Cellectis SA based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Cellectis. We calculate exposure to Cellectis's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Cellectis's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 18 K | 17.1 K | |
| Pretax Profit Margin | (154.26) | (146.54) | |
| Operating Profit Margin | (128.88) | (122.43) | |
| Net Loss | (133.85) | (127.16) | |
| Gross Profit Margin | 0.02 | 0.02 |
Cellectis Growth Indicators
Investing in growth stocks can be very risky. If the company such as Cellectis does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 57 M |
Cellectis Current Valuation Indicators
Cellectis' valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Cellectis' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Cellectis, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Cellectis' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Cellectis' worth.Additional Tools for Cellectis Stock Analysis
When running Cellectis' price analysis, check to measure Cellectis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cellectis is operating at the current time. Most of Cellectis' value examination focuses on studying past and present price action to predict the probability of Cellectis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cellectis' price. Additionally, you may evaluate how the addition of Cellectis to your portfolios can decrease your overall portfolio volatility.